Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxycodone hydrochloride
Drug ID BADD_D01646
Description Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917.[A178696] It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label] The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.[L6460]
Indications and Usage Oxycodone is indicated for the treatment of moderate to severe pain.[Label] There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label]
Marketing Status approved; illicit; investigational
ATC Code N02AA05
DrugBank ID DB00497
KEGG ID D00847
MeSH ID D010098
PubChem ID 5462350
TTD Drug ID D07WPQ
NDC Product Code 31722-918; 0115-1560; 42806-008; 42858-001; 43386-433; 43386-434; 50383-961; 57664-187; 63629-1930; 63629-4606; 63629-7399; 63629-8889; 66689-403; 70752-137; 71335-0115; 72162-1749; 81140-103; 0904-6828; 10702-056; 10702-057; 13107-055; 0093-5731; 31722-917; 0121-4839; 42806-007; 57664-224; 59011-430; 0406-8557; 68094-801; 68462-347; 69344-113; 0054-0390; 71930-023; 61960-9143; 10702-008; 17856-0023; 0115-1562; 0121-0826; 42858-004; 42858-010; 47781-263; 55700-174; 57664-371; 59011-420; 59011-460; 62559-151; 63629-1927; 63629-2104; 69344-213; 70752-136; 71335-1421; 71335-1422; 72162-1334; 60432-706; 63629-8526; 66689-025; 67296-1595; 0406-8520; 68071-2536; 68308-145; 71335-1245; 71335-9606; 0792-2936; 38779-0725; 69988-0034; 0121-4827; 42858-005; 43386-920; 55700-509; 57664-370; 62559-167; 67296-1560; 0406-0552; 0406-8510; 71335-1414; 72162-1336; 72189-094; 72865-129; 0904-6678; 10702-018; 10702-023; 13107-057; 0115-1556; 0121-0827; 42806-006; 47781-264; 63629-1174; 67296-1324; 0406-8515; 0406-8530; 68071-2899; 68084-983; 68462-204; 71335-1413; 71930-022; 72162-1335; 81140-101; 10702-009; 0093-5733; 0093-5734; 23635-582; 0115-1561; 42858-003; 59011-415; 59011-440; 63629-1928; 64950-354; 66689-401; 67296-1376; 0406-8556; 71335-1361; 72865-128; 81140-102; 51927-1008; 17856-0390; 0115-1557; 0115-1559; 43386-431; 59011-410; 63629-1929; 63629-8890; 64950-353; 64950-901; 67296-1040; 67296-1434; 68084-354; 68308-020; 43386-430; 68084-968; 68084-975; 68094-005; 71335-2126; 72189-095; 49452-0034; 10702-183; 13107-056; 0093-5732; 0115-1558; 42806-009; 42858-002; 47781-265; 57664-223; 60687-406; 63629-3775; 0527-1774; 72162-1337; 51634-0002; 10702-171; 67509-006; 23635-581; 42806-005; 43386-432; 50383-964; 59011-480
UNII C1ENJ2TE6C
Synonyms Oxycodone | Dihydrone | Oxycone | Dihydrohydroxycodeinone | Oxycodeinon | Eucodal | Theocodin | Oxycodone Hydrochloride | Oxycontin | Pancodine | Dinarkon | Oxiconum
Chemical Information
Molecular Formula C18H22ClNO4
CAS Registry Number 124-90-3
SMILES CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperaesthesia23.03.03.080; 17.02.06.004--Not Available
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkinesia17.01.02.008--Not Available
Hypersensitivity10.01.03.003--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hyponatraemia14.05.04.002--
Hypotension24.06.03.002--
Hypotonia17.05.02.002; 15.05.04.008--Not Available
Ileus07.13.01.001--
Increased appetite14.03.01.003; 08.01.09.027--Not Available
Infection11.01.08.002--Not Available
Influenza22.07.02.001; 11.05.03.001--Not Available
Injury12.01.08.004--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Iron deficiency anaemia14.13.02.001; 01.03.01.002--Not Available
Laryngospasm22.04.02.002--
Leukopenia01.02.02.001--Not Available
Libido decreased21.03.02.005; 19.08.03.001--
Lung disorder22.02.07.001--Not Available
Lymphadenopathy01.09.01.002--Not Available
Malaise08.01.01.003--
Migraine24.03.05.003; 17.14.02.001--Not Available
Muscle twitching15.05.03.005--Not Available
Myalgia15.05.02.001--
Nausea07.01.07.001--
Neck pain15.03.04.009--
Nervousness19.06.02.003--Not Available
Neuralgia17.02.07.005--
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages